Clinical Study

Effect and Safety of Mycophenolate Mofetil in Idiopathic Pulmonary Fibrosis

Figure 2

Diffusion capacity of the lung for carbon monoxide (DLCO) fluctuations over time for each subject. Each line represents measurements made in a single subject. A time point 0 month indicates when MMF treatment was commenced.
849035.fig.002